Craig Mayer, Nick WIlliams, Vojtech Huser
Lister Hill National Center for Biomedical Communications, National Library of Medicine, NIH, Bethesda, MD

See the full regCTG repository at https://github.com/lhncbc/CRI/tree/master/regCTG

To return to the list of conditions and view other reports go to https://lhncbc.github.io/CRI/regCTG/regCTG-condition_report_links.html


Study Counts

Type Study_count
Total_Studies 288
interventional 231
Observational 51
Registry 6

Studies over Time by Start Date

```

Interventional Trials

Intervention Type

intervention_type Study_Count
Drug 80
Other 24
Behavioral 17
Drug|Other 12
Biological|Drug 11
Device 11
Drug|placebo 11
Dietary Supplement 9
Procedure 7
Behavioral|Other 5
Drug|Procedure 5
Radiation 4
Biological 3
Device|Drug 3
Diagnostic Test 3
Other|Procedure 3
Drug|Other|Procedure 2
Drug|Radiation 2
Behavioral|Dietary Supplement 1
Behavioral|Other|Procedure 1
Behavioral|Procedure 1
Biological|Device|Drug 1
Biological|Drug|Other 1
Biological|Other 1
Biological|Other|Procedure 1
Combination Product 1
Device|Other 1
Diagnostic Test|Other 1
Diagnostic Test|Other|Procedure 1
Dietary Supplement|Other 1
Dietary Supplement|placebo 1
Drug|Genetic|Other 1
Drug|Other|placebo 1
Drug|Other|Radiation 1
Drug|Procedure|Radiation 1
Other|placebo 1
Other|Procedure|Radiation 1

Count of Studies by Intervention (normalized and mapped)

Interventions over Time

Yearly studies for each intervention by start date

Studies by Country

Country Study_Count
United States 114
China 20
NA 10
Canada 8
France 7
United Kingdom 7
Korea, Republic of 6
Netherlands 6
Denmark 5
Germany 4
United States|Canada 4
Cuba 3
Italy 3
Switzerland 3
Taiwan 3
Sweden 2
Australia 1
Belgium|France|Spain 1
Brazil|Canada|Cyprus|United Kingdom 1
China|Japan|Korea, Republic of|Taiwan 1
Finland 1
Georgia|Hong Kong|India|Moldova, Republic of|Serbia|Taiwan|Thailand|Ukraine 1
Hong Kong 1
Ireland 1
Israel 1
Japan 1
Japan|Korea, Republic of 1
Japan|Spain 1
Korea, Republic of|United States|Canada|Mexico|Russian Federation|Taiwan 1
Luxembourg 1
Norway 1
Russian Federation 1
Saudi Arabia 1
Spain 1
Tunisia 1
United States|Argentina|Brazil|Canada|Chile|China|Estonia|Hong Kong|Hungary|India|Israel|Italy|Korea, Republic of|Mexico|Netherlands|Peru|Poland|Puerto Rico|Russian Federation|Taiwan|Thailand|Turkey|Ukraine 1
United States|Australia|Austria|Belgium|Canada|Czechia|Denmark|Finland|France|Germany|Hong Kong|Hungary|Ireland|Italy|Korea, Republic of|Netherlands|Portugal|Singapore|Spain|Taiwan|United Kingdom 1
United States|Belgium|China|France|Germany|Hong Kong|Italy|Korea, Republic of|Netherlands|Singapore|Spain|Taiwan|United Kingdom 1
United States|Canada|France 1
United States|Germany 1
United States|Japan 1
United States|Mexico 1

Sites per Study

Site_count Study_Count
1 156
2 23
3 9
4 9
5 4
6 3
7 5
8 1
9 1
11 1
15 2
16 2
17 3
20 1
22 1
23 1
26 1
27 1
61 1
66 1
86 1
112 1
183 1
188 1
434 1

Phase

Phase Study_Count
N/A 73
Phase 2 61
Phase 1 49
Phase 1/Phase 2 24
Phase 3 11
Phase 4 10
Early Phase 1 2
Phase 2/Phase 3 1

Number of Arms

Number_of_Arms Count_of_Studies
1 98
2 82
3 9
4 11
5 1
7 2
8 1
NA 27

Enrollment Metrics by Phase

Measure Early.Phase.1 N.A Phase.1 Phase.1.Phase.2 Phase.2 Phase.2.Phase.3 Phase.3 Phase.4
Min. 40 4.000 7.00000 19.000 3.00000 538 30.0000 20.0
1st Qu. 57 32.000 19.00000 44.000 34.25000 538 113.5000 40.5
Median 74 80.000 27.00000 70.000 57.50000 538 273.0000 60.5
Mean 74 1057.479 46.42857 120.381 77.34483 538 331.8182 76.4
3rd Qu. 91 248.000 49.00000 110.000 92.25000 538 512.5000 115.0
Max. 108 34906.000 328.00000 527.000 252.00000 538 866.0000 160.0

Trial Group Type

group_type Group_Count
Experimental 249
Active Comparator 52
NA 27
No Intervention 23
Other 22
Placebo Comparator 11
Sham Comparator 3

Intervention Model

intervention_model Study_Count
Single Group Assignment 118
Parallel Assignment 85
NA 13
Sequential Assignment 9
Crossover Assignment 4
Factorial Assignment 2

Primary Purpose

primary_purpose Study_Count
Treatment 153
Supportive Care 38
Diagnostic 16
Health Services Research 7
Other 7
Prevention 5
Screening 3
Basic Science 1
NA 1

Observational Studies

Studies by Country

Country Study_Count
United States 22
France 4
Canada 3
China 3
Korea, Republic of 3
United Kingdom 3
Denmark 2
Spain 2
Taiwan 2
Egypt 1
Germany 1
Germany|Serbia|United Kingdom 1
Hong Kong 1
Morocco 1
NA 1
Norway 1

Sites per Study

Site_count Study_Count
1 44
2 1
3 2
6 1
7 1
17 1
19 1

Enrollment Metrics

Measure Observational
Min 17.00
1st Qu 103.00
Median 374.00
Mean 98298.53
3rd Qu 1638.00
Max 4710504.00

Observation Model

observational_model Study_Count
Cohort 32
Case-Only 6
Other 5
Case-Control 3
NA 2
Case Control 1
Ecologic or Community 1
Family-Based 1

Time Perspective

time_perspective Study_Count
Prospective 33
Retrospective 12
Cross-Sectional 3
Other 2
NA 1

Registries

Studies by Country

Country Study_Count
China 3
France 1
Morocco 1
United States 1

Sites per Study

Site_count Study_Count
1 4
4 1
19 1

Enrollment Metrics

Measure Registries
Min 30
1st Qu 125
Median 350
Mean 1055
3rd Qu 1250
Max 4000

Registry Model

observational_model Study_Count
Cohort 5
Ecologic or Community 1

Time Perspective

time_perspective Study_Count
Prospective 6

Follow-up

target_duration Study_Count
3 Years 2
1 Month 1
24 Months 1
30 Days 1
48 Months 1

Overview of Studies

Interventional Trials

#If less then 500 trials

nct_id brief_title link overall_status source primary_completion_date
NCT04137289 A First-in-human Phase Ia/b, Open Label, Multicentre, Dose Escalation Study of BI 905711 in Patients With Advanced Gastrointestinal Cancers https://ClinicalTrials.gov/show/NCT04137289 Recruiting Boehringer Ingelheim 2023-04-04
NCT03360695 Bridge: Proactive Psychiatry Consultation and Case Management for Patients With Cancer https://ClinicalTrials.gov/show/NCT03360695 Recruiting Massachusetts General Hospital 2022-05-15
NCT03343301 A Study of FPA144 Combined With Modified FOLFOX6 in Gastric/Gastroesophageal Cancer https://ClinicalTrials.gov/show/NCT03343301 Active, not recruiting Five Prime Therapeutics, Inc. 2022-07-01
NCT03337087 Liposomal Irinotecan, Fluorouracil, Leucovorin Calcium, and Rucaparib in Treating Patients With Metastatic Pancreatic, Colorectal, Gastroesophageal, or Biliary Cancer https://ClinicalTrials.gov/show/NCT03337087 Recruiting Academic and Community Cancer Research United 2020-11-07
NCT03331406 Physical Activity In Gastrointestinal Cancer https://ClinicalTrials.gov/show/NCT03331406 Completed Dana-Farber Cancer Institute 2019-01-22
NCT03329690 DS-8201a in Human Epidermal Growth Factor Receptor 2 (HER2)-Expressing Gastric Cancer [DESTINY-Gastric01] https://ClinicalTrials.gov/show/NCT03329690 Active, not recruiting Daiichi Sankyo, Inc. 2020-09-30
NCT03321396 Hydrogel Injection to Assist Endoscopic Submucosal Dissection https://ClinicalTrials.gov/show/NCT03321396 Completed National Cheng-Kung University Hospital 2018-08-20
NCT03309917 The Effect of Blood Pressure on Cerebral Blood Flow During Propofol Anesthesia https://ClinicalTrials.gov/show/NCT03309917 Completed Rigshospitalet, Denmark 2018-04-19
NCT03306693 Educational Intervention to Increase the Emotional Competence of Patients With Oesogastric and Bronchopulmonary Cancers https://ClinicalTrials.gov/show/NCT03306693 Recruiting University Hospital, Lille 2019-10-31
NCT03271255 Apatinib Versus Bevacizumab in Second-line Therapy for Colorectal Cancer(ABST-C) https://ClinicalTrials.gov/show/NCT03271255 Recruiting Shenzhen People’s Hospital 2022-09-30
NCT03267524 Walking for Recovery From Surgery in Improving Quality of Life in Older Adults With Lung or Gastrointestinal Cancer and Their Family Caregivers https://ClinicalTrials.gov/show/NCT03267524 Active, not recruiting City of Hope Medical Center 2020-11-30
NCT03221335 EUS-guided RFA for Solid Abdominal Neoplasms https://ClinicalTrials.gov/show/NCT03221335 Recruiting Chinese University of Hong Kong 2021-04-30
NCT03190941 Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12V Variant of Mutated RAS in HLA-A*11:01 Patients https://ClinicalTrials.gov/show/NCT03190941 Recruiting National Institutes of Health Clinical Center (CC) 2027-06-29
NCT03117348 Gradual Versus Immediate Goal-dose Enteral Nutrition in Abdominal Surgery Patients https://ClinicalTrials.gov/show/NCT03117348 Completed Jinling Hospital, China 2018-12-24
NCT03115957 Early Versus Delayed Parenteral Nutrition in Abdominal Surgical Patients https://ClinicalTrials.gov/show/NCT03115957 Completed Jinling Hospital, China 2018-12-30
NCT03115398 A Simple Walking Program to Enhance Concurrent Chemoradiotherapy Delivery https://ClinicalTrials.gov/show/NCT03115398 Active, not recruiting Albert Einstein College of Medicine 2020-03-03
NCT03086291 A Phase I Study of High Dose Simvastatin in Patients With Gastrointestinal Tract Cancer Who Failed to Standard Chemotherapy https://ClinicalTrials.gov/show/NCT03086291 Recruiting Samsung Medical Center 2020-09-30
NCT03072472 BowelScope: Accuracy of Detection Using ENdocuff Optimisation of Mucosal Abnormalities https://ClinicalTrials.gov/show/NCT03072472 Completed South Tyneside and Sunderland NHS Foundation Trust 2018-02-13
NCT02923934 A Phase II Trial of Ipilimumab and Nivolumab for the Treatment of Rare Cancers https://ClinicalTrials.gov/show/NCT02923934 Active, not recruiting Olivia Newton-John Cancer Research Institute 2023-08-31
NCT02897778 Cardiac Safety Study of Entinostat in Men and Women With Advanced Solid Tumors https://ClinicalTrials.gov/show/NCT02897778 Completed Syndax Pharmaceuticals 2017-03-31
NCT02859064 Study of Lanreotide in Patients With Metastatic Gastrointestinal Neuroendocrine Tumors Who Are Undergoing Liver-directed Radioembolization With Yttrium-90 Microspheres https://ClinicalTrials.gov/show/NCT02859064 Active, not recruiting SCRI Development Innovations, LLC 2020-04-30
NCT02853474 Early Palliative Care in Patients With Metastatic Upper Gastrointestinal Cancers Treated With First-line Chemotherapy https://ClinicalTrials.gov/show/NCT02853474 Recruiting Centre Oscar Lambret 2021-10-31
NCT02842047 The Mediating Effects of Decentering on Self-Management of Stress and End of Life Planning https://ClinicalTrials.gov/show/NCT02842047 Completed Case Comprehensive Cancer Center 2018-03-09
NCT02797197 Feasibility of Systematic Handgrip Strength (HGS) Testing and Short-term Changes in Muscle Strength in Digestive Cancer Patients Treated by Chemotherapy https://ClinicalTrials.gov/show/NCT02797197 Completed CHU de Reims 2017-02-15
NCT02795988 A Study of IMU-131(HER-Vaxx) and Chemotherapy Compared to Chemotherapy Only in Patients With HER2 Positive Advanced Gastric Cancer https://ClinicalTrials.gov/show/NCT02795988 Recruiting Imugene Limited 2020-12-31
NCT02785887 Impact of Geriatrician Interventions on Chemotherapy Delivery in Vulnerable Elderly Oncology Patients https://ClinicalTrials.gov/show/NCT02785887 Completed Azienda USL 4 Prato 2018-09-25
NCT02785783 Endoringsâ„¢ Assisted Colonoscopy Versus Standard Colonoscopy for Polyp Detection https://ClinicalTrials.gov/show/NCT02785783 Completed Portsmouth Hospitals NHS Trust 2018-08-07
NCT02784652 Efficacy of Radiotherapy in Combination With Zoledronic Acid in Bone Metastasis Patients With Gastrointestinal Tumors https://ClinicalTrials.gov/show/NCT02784652 Completed Severance Hospital 2017-02-28
NCT02760199 89Zr-AMG211 PET Imaging Study https://ClinicalTrials.gov/show/NCT02760199 Completed University Medical Center Groningen 2017-05-03
NCT02744651 EUS-Endodrill vs. EUS-FNA for Diagnosis of Submucosal Tumors in the Upper GI Tract https://ClinicalTrials.gov/show/NCT02744651 Recruiting Region Skane 2020-09-30
NCT02742935 A Study to Evaluate the Safety and Tolerability of Using the SHR-1210 by Advanced Solid Tumor Subjects https://ClinicalTrials.gov/show/NCT02742935 Active, not recruiting Jiangsu HengRui Medicine Co., Ltd. 2019-05-06
NCT02713269 Thermal Ablation and Spine Stereotactic Radiosurgery in Treating Patients With Spine Metastases at Risk for Compressing the Spinal Cord https://ClinicalTrials.gov/show/NCT02713269 Recruiting M.D. Anderson Cancer Center 2022-07-01
NCT02677129 Physical Function and Activities of Daily Living in Cancer Patients During Chemotherapy https://ClinicalTrials.gov/show/NCT02677129 Completed Goethe University 2016-09-30
NCT02595320 Capecitabine in Metastatic Breast and GI Cancers https://ClinicalTrials.gov/show/NCT02595320 Recruiting University of Kansas Medical Center 2020-12-31
NCT02585362 Whey Protein Supplement in Combination With Physical Exercise and Nutrition Program https://ClinicalTrials.gov/show/NCT02585362 Completed Kantonsspital Winterthur KSW 2018-10-31
NCT02584244 Feasibility of the LUM Imaging System for Detection of Gastrointestinal Cancers https://ClinicalTrials.gov/show/NCT02584244 Recruiting Lumicell, Inc. 2020-12-31
NCT02573974 Skeletal Muscle Energy Metabolism in Undernourished Patients With Gastrointestinal Cancer https://ClinicalTrials.gov/show/NCT02573974 Completed University Hospital, Tours 2018-12-04
NCT02038114 The Impact of a Patient Education Intervention for Ambulatory Oncology Patients https://ClinicalTrials.gov/show/NCT02038114 Completed Sunnybrook Health Sciences Centre 2014-06-30
NCT02631590 Copanlisib (BAY 80-6946) in Combination With Gemcitabine and Cisplatin in Advanced Cholangiocarcinoma https://ClinicalTrials.gov/show/NCT02631590 Active, not recruiting H. Lee Moffitt Cancer Center and Research Institute 2019-11-23
NCT03403465 Intratreatment FDG-PET During Radiation Therapy for Gynecologic and Gastrointestinal Cancers https://ClinicalTrials.gov/show/NCT03403465 Recruiting Duke University 2021-02-28
NCT02507414 Mesenteric Traction Syndrome During Upper Gastrointestinal Surgery https://ClinicalTrials.gov/show/NCT02507414 Completed Rigshospitalet, Denmark 2016-09-30
NCT02486198 Monosialotetrahexosylganglioside for Treatment of Oxaliplatin Induced Neurotoxicity in Gastrointestinal Cancer https://ClinicalTrials.gov/show/NCT02486198 Completed Tianjin Medical University Cancer Institute and Hospital 2018-01-11
NCT02485561 Evaluating Strategies to Present Colon Cancer Screening Information https://ClinicalTrials.gov/show/NCT02485561 Completed Washington University School of Medicine 2017-01-31
NCT02450656 Afatinib and Selumetinib in Advanced KRAS Mutant and PIK3CA Wildtype Non-small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT02450656 Recruiting The Netherlands Cancer Institute 2019-05-31
NCT02444572 Comparison of Thromboembolic Events in Patients Undergoing Thromboprophylactic Treatment With ENOXA® vs Lovenox® https://ClinicalTrials.gov/show/NCT02444572 Recruiting Les Laboratoires des Médicaments Stériles 2020-12-31
NCT02381561 Ropidoxuridine in Treating Patients With Advanced Gastrointestinal Cancer Undergoing Radiation Therapy https://ClinicalTrials.gov/show/NCT02381561 Active, not recruiting National Cancer Institute (NCI) 2018-11-08
NCT02356471 Consumer-Based Activity Monitor in Evaluating and Measuring Activity of Older Patients With Abdominal Cancer Undergoing Surgery https://ClinicalTrials.gov/show/NCT02356471 Completed Wake Forest University Health Sciences 2016-10-31
NCT02335619 Early Integrated Supportive Care Study for Gastrointestinal Cancer Patients https://ClinicalTrials.gov/show/NCT02335619 Completed British Columbia Cancer Agency 2018-12-31
NCT02333188 Genetic Analysis-Guided Dosing of FOLFIRABRAX in Treating Patients With Advanced Gastrointestinal Cancer https://ClinicalTrials.gov/show/NCT02333188 Completed University of Chicago 2017-12-31
NCT02319018 Alisertib and Combination Chemotherapy in Treating Patients With Gastrointestinal Tumors https://ClinicalTrials.gov/show/NCT02319018 Completed National Cancer Institute (NCI) 2018-09-29
NCT02293954 Copper Cu 64 Anti-CEA Monoclonal Antibody M5A PET in Diagnosing Patients With CEA Positive Cancer https://ClinicalTrials.gov/show/NCT02293954 Active, not recruiting City of Hope Medical Center 2020-06-30
NCT02275403 Standard Care Alone or With Acupuncture for CIPN in Breast Cancer and Multiple Myeloma https://ClinicalTrials.gov/show/NCT02275403 Completed The Christie NHS Foundation Trust 2018-12-17
NCT02259725 Regorafenib in Treating Patients With Advanced or Metastatic Neuroendocrine Tumors https://ClinicalTrials.gov/show/NCT02259725 Active, not recruiting University of Southern California 2020-08-16
NCT03385577 Yoga for Psychological Distress in Gynecologic, Gastrointestinal, or Thoracic Cancer https://ClinicalTrials.gov/show/NCT03385577 Recruiting University of Florida 2020-05-31
NCT02222259 A Feasibility Trial of Geriatric Assessment and Management for Older Cancer Patients https://ClinicalTrials.gov/show/NCT02222259 Completed University of Toronto 2016-08-31
NCT02216799 Glargine Insulin vs.Continuous Regular Insulin in Diabetic Surgical Patients Receiving Parenteral Nutrition (GLUCOSE-in-PN) https://ClinicalTrials.gov/show/NCT02216799 Completed King Faisal Specialist Hospital & Research Center 2015-08-31
NCT02192333 Survivorship Care in Reducing Symptoms in Young Adult Cancer Survivors https://ClinicalTrials.gov/show/NCT02192333 Active, not recruiting Fred Hutchinson Cancer Research Center 2017-10-07
NCT02174549 Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer https://ClinicalTrials.gov/show/NCT02174549 Active, not recruiting Teclison Ltd. 2020-08-31
NCT02148159 Acupuncture for Unintentional Weight Loss and Anorexia With GI Cancer https://ClinicalTrials.gov/show/NCT02148159 Completed University of Florida 2016-05-31
NCT02140593 The Laparotomy Study https://ClinicalTrials.gov/show/NCT02140593 Completed Herlev Hospital 2016-05-31
NCT02130427 A Volume, Motion, and Anatomically Adaptive Approach to Photon and Proton Beam Radiotherapy https://ClinicalTrials.gov/show/NCT02130427 Completed Abramson Cancer Center of the University of Pennsylvania 2019-10-31
NCT02092298 Laparoscopic Hyperthermic Intraperitoneal Chemoperfusion (HIPEC) for Metastatic Gastric Cancer https://ClinicalTrials.gov/show/NCT02092298 Completed M.D. Anderson Cancer Center 2020-05-12
NCT01291407 A Phase I Study of S-1 in Combination With Radiotherapy in Locally Advanced or Recurrent Gastric Cancer https://ClinicalTrials.gov/show/NCT01291407 Completed Chinese Academy of Medical Sciences 2013-08-31
NCT02056015 A Phase I Study of MLN6907 in Patients With Metastatic Colorectal https://ClinicalTrials.gov/show/NCT02056015 Completed Takeda 2015-09-30
NCT02045368 Study of Insulin-like Growth Factor (IGF)-Methotrexate Conjugate in the Treatment of Advanced Tumors Expressing IGF-1R https://ClinicalTrials.gov/show/NCT02045368 Completed IGF Oncology, LLC 2016-09-30
NCT01996306 A Phase III Study of 2nd-line XELIRI ± Bevacizumab vs. FOLFIRI ± Bevacizumab in mCRC https://ClinicalTrials.gov/show/NCT01996306 Completed Epidemiological and Clinical Research Information Network 2017-11-20
NCT01995084 In Vivo Assessment of Hypoxia in Gastro-intestinal Cancer Using 18F-HX4-PET: an Optimization and Reproducibility Study https://ClinicalTrials.gov/show/NCT01995084 Completed Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 2014-06-30
NCT01982994 Intervention to Motivate Standing &Walking in Gastrointestinal Cancer Surgical Patients https://ClinicalTrials.gov/show/NCT01982994 Completed Milton S. Hershey Medical Center 2015-07-31
NCT01976494 The Efficacy and Safety of Accufuser Omnibus® (Elastomeric Infusion Pump); Comparative Clinical Trial https://ClinicalTrials.gov/show/NCT01976494 Completed Yonsei University 2014-07-31
NCT01964430 Nab-paclitaxel and Gemcitabine vs Gemcitabine Alone as Adjuvant Therapy for Patients With Resected Pancreatic Cancer (the “Apact” Study) https://ClinicalTrials.gov/show/NCT01964430 Active, not recruiting Celgene 2018-12-31
NCT01946854 Crossover Trial of Systemic Chemotherapy in Patients With Metastatic Well-Differentiated Mucinous Appendiceal Adenocarcinomas With Pseudomyxoma Peritonei https://ClinicalTrials.gov/show/NCT01946854 Recruiting M.D. Anderson Cancer Center 2021-07-31
NCT01927965 Study of Minnelideâ„¢ in Patients With Advanced GI Tumors https://ClinicalTrials.gov/show/NCT01927965 Completed Minneamrita Therapeutics LLC 2016-10-31
NCT01916447 A Phase I Study of TAS-102 in Patients With Advanced Gastrointestinal Tumors. https://ClinicalTrials.gov/show/NCT01916447 Completed Taiho Oncology, Inc. 2017-09-30
NCT01912131 Person-Centered Oncology Care and Choices (P-COCC): Piloting and Initial Randomized Testing of a Combined Values Narrative Interview and Video Education Advance Care Planning Program in Gastrointestinal Oncology Patients https://ClinicalTrials.gov/show/NCT01912131 Completed Memorial Sloan Kettering Cancer Center 2020-01-31
NCT01845337 Study to Compare Cardiovascular Side Effects of Teysuno Versus Capecitabine https://ClinicalTrials.gov/show/NCT01845337 Active, not recruiting University of Edinburgh 2021-07-30
NCT01841736 Pazopanib Hydrochloride in Treating Patients With Progressive Carcinoid Tumors https://ClinicalTrials.gov/show/NCT01841736 Active, not recruiting National Cancer Institute (NCI) 2019-03-05
NCT01833637 Electronic Patient Reported Symptom Assessment https://ClinicalTrials.gov/show/NCT01833637 Completed Northwestern University 2015-06-30
NCT01832116 89Zr-MMOT PET Imaging in Pancreatic and Ovarian Cancer Patients https://ClinicalTrials.gov/show/NCT01832116 Completed University Medical Center Groningen 2014-05-31
NCT01790035 Probiotic LGG for Prevention of Side Effects in Patients Undergoing Chemoradiation for Gastrointestinal Cancer https://ClinicalTrials.gov/show/NCT01790035 Active, not recruiting Washington University School of Medicine 2017-01-12
NCT01730586 Abraxane in CIMP-High Colorectal and Small Bowel Adenocarcinomas https://ClinicalTrials.gov/show/NCT01730586 Completed M.D. Anderson Cancer Center 2016-08-31
NCT01700062 Medium Calorie Parenteral Nutrition on Patients With Gastrointestinal Cancer Undergoing Surgery https://ClinicalTrials.gov/show/NCT01700062 Completed Kaohsiung Medical University Chung-Ho Memorial Hospital 2008-11-30
NCT01658813 5-Fluorouracil Followed by Interferon-alfa-2b in Previously-treated Metastatic Gastrointestinal, Kidney, or Lung Cancer https://ClinicalTrials.gov/show/NCT01658813 Completed Western Regional Medical Center 2014-07-31
NCT01640665 Pilot Study of Sorafenib and Bi-weekly Capecitabine in Patients With Advanced Breast and Gastrointestinal Tumors https://ClinicalTrials.gov/show/NCT01640665 Completed Yale University 2014-08-31
NCT01639911 Phase I Study of MLN8237 and Pazopanib in Patients With Solid Tumors https://ClinicalTrials.gov/show/NCT01639911 Completed University of Illinois at Chicago 2016-07-28
NCT01625351 A Study of CD45RA+ Depleted Haploidentical Stem Cell Transplantation in Children With Relapsed or Refractory Solid Tumors and Lymphomas https://ClinicalTrials.gov/show/NCT01625351 Active, not recruiting St. Jude Children’s Research Hospital 2020-09-18
NCT01567488 Phase II Study of Everolimus Combined With Octreotide LAR to Treat Advanced GI NET https://ClinicalTrials.gov/show/NCT01567488 Completed Grupo Espanol de Tumores Neuroendocrinos 2014-09-01
NCT02024607 A Study of BBI608 in Combination With Standard Chemotherapies in Adult Patients With Advanced Gastrointestinal Cancer https://ClinicalTrials.gov/show/NCT02024607 Active, not recruiting Boston Biomedical, Inc 2020-06-30
NCT01552291 The Impact of Preoperative Oral Glutamine Intake on the Immunocompetence and Outcomes of Malnourished Patients Undergoing Major Abdominal Surgery Due to Malignancies https://ClinicalTrials.gov/show/NCT01552291 Completed University Hospital Inselspital, Berne 2018-02-10
NCT01540968 Nutrition and Physical Exercise Study https://ClinicalTrials.gov/show/NCT01540968 Completed Kantonsspital Winterthur KSW 2015-03-31
NCT01476592 A Biological Study of Resveratrol’s Effects on Notch-1 Signaling in Subjects With Low Grade Gastrointestinal Tumors https://ClinicalTrials.gov/show/NCT01476592 Completed University of Wisconsin, Madison 2013-10-31
NCT01449864 Proton Radiotherapy for Upper Gastrointestinal Malignancies https://ClinicalTrials.gov/show/NCT01449864 Completed Abramson Cancer Center of the University of Pennsylvania 2015-12-31
NCT03866525 OH2 Oncolytic Viral Therapy in Solid Tumors https://ClinicalTrials.gov/show/NCT03866525 Recruiting Wuhan Binhui Biotechnology Co., Ltd. 2020-12-31
NCT01434069 Phase I Trial of Combination of FOLFIRI and SOM 230 https://ClinicalTrials.gov/show/NCT01434069 Completed H. Lee Moffitt Cancer Center and Research Institute 2015-12-31
NCT01423799 Immunonutrition and Quality of Life of Cancer Patients Undergoing Oncological Treatment https://ClinicalTrials.gov/show/NCT01423799 Completed Nestlé 2015-10-31
NCT01422993 Pilot Study of Strength and Balance Training Program for Persons With Oxaliplatin Induced Neuropathy https://ClinicalTrials.gov/show/NCT01422993 Completed H. Lee Moffitt Cancer Center and Research Institute 2016-04-30
NCT01375699 Doxorubicin With or Without Sildenafil, With Analysis of Cardiac Markers https://ClinicalTrials.gov/show/NCT01375699 Completed Virginia Commonwealth University 2017-08-04
NCT04393584 FOLFIRINOX vs FLOT Chemotherapy for Resectable Gastric or Esophagogastric Junction Adenocarcinoma https://ClinicalTrials.gov/show/NCT04393584 Recruiting Blokhin’s Russian Cancer Research Center 2024-01-01
NCT04298489 Drug Sensitivity Screening for Gastrointestinal Cancer https://ClinicalTrials.gov/show/NCT04298489 Recruiting Beijing Cancer Hospital 2022-04-30
NCT04273061 Investigating the Effects of Atezolizumab in People Whose Tumour DNA or RNA Indicates Possible Sensitivity https://ClinicalTrials.gov/show/NCT04273061 Recruiting British Columbia Cancer Agency 2024-10-31
NCT04207463 A Study of Anlotinib and AK105 Injection in Subjects With Gastrointestinal Tumors, Urinary System Tumors, Neuroendocrine Tumors https://ClinicalTrials.gov/show/NCT04207463 Recruiting Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 2020-12-31
NCT04201730 Study on the Efficacy and Safety of Enhanced Recovery After Surgery (ERAS)in Gastrointestinal Cancer https://ClinicalTrials.gov/show/NCT04201730 Recruiting Huashan Hospital 2020-12-31
NCT04197310 Cabozantinib and Nivolumab for Carcinoid Tumors https://ClinicalTrials.gov/show/NCT04197310 Recruiting Dana-Farber Cancer Institute 2021-12-26
NCT04196465 Phase II Study of Neoadjuvant Immune Checkpoint Inhibitor in Patients With Resectable Gastrointestinal Cancers https://ClinicalTrials.gov/show/NCT04196465 Recruiting Asan Medical Center 2026-09-09
NCT04171141 Study to Test the Safety and Tolerability of PF-07062119 in Patients With Selected Advanced or Metastatic Gastrointestinal Tumors. https://ClinicalTrials.gov/show/NCT04171141 Recruiting Pfizer 2023-06-14
NCT04145297 Ulixertinib (BVD-523) and Hydroxychloroquine in Patients w Advanced MAPK-Mutated Gastrointestinal Adenocarcinomas https://ClinicalTrials.gov/show/NCT04145297 Recruiting University of Utah 2023-01-30
NCT04131426 Evaluating the Combined Intervention of Nutritional Supplementation (Remune) and Exercise in Patients With Cancer Cachexia https://ClinicalTrials.gov/show/NCT04131426 Recruiting University of Rochester 2022-04-01
NCT04084249 Circulating Tumor DNA Analysis to Optimize the Operative and Postoperative Treatment for Patients With Colorectal Cancer - Intervention Trial 2 https://ClinicalTrials.gov/show/NCT04084249 Recruiting University of Aarhus 2022-12-01
NCT04080843 Anlotinib Hydrochloride Capsules Combined With CAPEOX in RAS and BRAF Wild-type mCRC Patients https://ClinicalTrials.gov/show/NCT04080843 Recruiting Zhejiang University 2020-08-31
NCT04077372 Assessment of a Serious Illness Conversation Guide (SICG) in Advanced Gastro-Intestinal Cancers https://ClinicalTrials.gov/show/NCT04077372 Recruiting Stanford University 2020-09-30
NCT04071431 A Questionnaire for Endoscopic Prediction Improvement of Gastrointestinal Cancer https://ClinicalTrials.gov/show/NCT04071431 Recruiting Shandong University 2021-04-30
NCT04032353 Medical Consortium for Screening Upper Gastrointestinal Cancers With Magnetically Controlled Capsule Gastroscopy https://ClinicalTrials.gov/show/NCT04032353 Recruiting Shandong University 2019-12-31
NCT04010227 Telephone Support for Advanced Gastrointestinal Cancer Patients and Caregivers https://ClinicalTrials.gov/show/NCT04010227 Recruiting Indiana University 2021-05-31
NCT03997617 Personalized Functional Profiling in Metastatic Gastrointestinal Cancer or Recurrent Glioblastoma Patients in Luxembourg. https://ClinicalTrials.gov/show/NCT03997617 Recruiting Luxembourg Institute of Health 2020-12-01
NCT03978078 A Clinicobiological Database in Metastatic Digestive Cancers https://ClinicalTrials.gov/show/NCT03978078 Recruiting Institut du Cancer de Montpellier - Val d’Aurelle 2021-04-30
NCT03958747 Ultrasound for the Detection of Oxaliplatin-Induced Peripheral Neuropathy https://ClinicalTrials.gov/show/NCT03958747 Recruiting Wake Forest University Health Sciences 2021-08-31
NCT03915171 Sensitivity and Specificity of NGS in Detecting bMSI in Patients With Gastric, Duodenal and Small Intestinal Cancer https://ClinicalTrials.gov/show/NCT03915171 Recruiting China Medical University, China 2019-12-01
NCT03858855 Inhaled Essential Oil Effect on Common QOL Concerns During Cancer Treatment https://ClinicalTrials.gov/show/NCT03858855 Completed Ohio State University Comprehensive Cancer Center 2020-04-13
NCT03850912 Symptom Management Implementation of Patient Reported Outcomes in Oncology https://ClinicalTrials.gov/show/NCT03850912 Recruiting Dana-Farber Cancer Institute 2023-05-31
NCT03812796 Epigenetic Modulation of the immunE Response in GastrointEstinal Cancers (EMERGE) https://ClinicalTrials.gov/show/NCT03812796 Recruiting Royal Marsden NHS Foundation Trust 2021-11-30
NCT03807518 Pre- and Post-Operative Exercise Program in Upper Gastrointestinal Cancers https://ClinicalTrials.gov/show/NCT03807518 Recruiting Royal College of Surgeons, Ireland 2020-07-31
NCT03800693 2 Versus 6 Hour Oxaliplatin Infusions in Patients With Gastrointestinal Cancers https://ClinicalTrials.gov/show/NCT03800693 Recruiting Emory University 2021-03-31
NCT03767660 Efficacy of Rapamycin (Sirolimus) in the Treatment of BRBNS, Hereditary or Sporadic Venous Malformation https://ClinicalTrials.gov/show/NCT03767660 Recruiting Peking Union Medical College Hospital 2022-01-01
NCT03745326 Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12D Variant of Mutated RAS in HLA-A*11:01 Patients https://ClinicalTrials.gov/show/NCT03745326 Recruiting National Institutes of Health Clinical Center (CC) 2027-12-01
NCT03724071 Study of TG6002 (VV TK-RR-FCU1) in Combination With 5-FC in Patients With Advanced Gastro-intestinal Tumors. https://ClinicalTrials.gov/show/NCT03724071 Recruiting Transgene 2020-12-31
NCT03723447 Intraoperative TAP Block With Bupivacaine/Dexamethasone Against Liposomal Bupivacaine (Exparel®) https://ClinicalTrials.gov/show/NCT03723447 Active, not recruiting Cedars-Sinai Medical Center 2019-12-31
NCT03717298 Evaluation of Ocoxin-Viusid® in Advanced Pancreatic Adenocarcinoma https://ClinicalTrials.gov/show/NCT03717298 Recruiting Catalysis SL 2020-10-30
NCT03704727 The Effects of Probiotics on Intestinal Permeability in Gastrointestinal Cancer Patients in Chemotherapy https://ClinicalTrials.gov/show/NCT03704727 Completed University of Copenhagen 2019-02-01
NCT03699332 Multi-modality Imaging in Peritoneal Carcinomatosis of Colorectal Origin https://ClinicalTrials.gov/show/NCT03699332 Recruiting Radboud University 2021-03-31
NCT03665714 Effects of Immunonutrition (Impact Oral®) in Patients Undergoing Surgery for Gastrointestinal Cancer https://ClinicalTrials.gov/show/NCT03665714 Recruiting Nestlé 2019-08-31
NCT03611309 Perioperative Palliative Care Surrounding Cancer Surgery for Patients & Their Family Members https://ClinicalTrials.gov/show/NCT03611309 Recruiting Stanford University 2021-02-28
NCT03602677 Indocyanine Green Fluorescence Imaging in Prevention of Colorectal Anastomotic Leakage https://ClinicalTrials.gov/show/NCT03602677 Recruiting Oulu University Hospital 2020-09-01
NCT03597581 A Study of RGX-202-01 With or Without FOLFIRI in Patients With Advanced Gastrointestinal Malignancies https://ClinicalTrials.gov/show/NCT03597581 Recruiting Rgenix, Inc. 2020-07-31
NCT03576872 The GI Binder: A Psychoeducational Intervention for Gastrointestinal Cancer Patients https://ClinicalTrials.gov/show/NCT03576872 Completed Dana-Farber Cancer Institute 2019-09-30
NCT03559543 Evaluation of Ocoxin®-Viusid® in Metastatic Colorectal Adenocarcinoma https://ClinicalTrials.gov/show/NCT03559543 Recruiting Catalysis SL 2020-11-30
NCT03549494 Evaluation of Ocoxin®-Viusid® in Advanced Stomach Cancer and Gastric Esophagogastric Junction https://ClinicalTrials.gov/show/NCT03549494 Recruiting Catalysis SL 2020-11-01
NCT03535727 A Study of Gemcitabine, Nab-paclitaxel, Capecitabine, Cisplatin, and Irinotecan in Metastatic Pancreatic Cancer https://ClinicalTrials.gov/show/NCT03535727 Recruiting Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 2021-06-30
NCT03531320 Study of D07001-Softgel Capsules in Subjects With Gastrointestinal Cancer in Dose-Escalation Phase and in Subjects With Biliary Tract Cancer in Dose-Expansion Phase https://ClinicalTrials.gov/show/NCT03531320 Recruiting InnoPharmax Inc. 2019-10-31
NCT03528863 Web-based Mindfulness Meditation in Reducing Distress in Participants With Metastatic Gastrointestinal Cancer and Their Caregivers https://ClinicalTrials.gov/show/NCT03528863 Active, not recruiting University of California, San Francisco 2019-02-28
NCT03515941 Postoperative Chemoradiation or Chemotherapy After Preoperative Chemotherapy for Gastric Cancers https://ClinicalTrials.gov/show/NCT03515941 Recruiting Baylor College of Medicine 2022-10-08
NCT03515356 Exercise to Reduce Chemotherapy-Induced Peripheral Neuropathy https://ClinicalTrials.gov/show/NCT03515356 Completed University of Michigan Rogel Cancer Center 2019-06-24
NCT03507998 Phase 1 Dose Escalation Study of CGX1321 in Subjects With Advanced Gastrointestinal Tumors https://ClinicalTrials.gov/show/NCT03507998 Recruiting Curegenix Inc. 2020-04-01
NCT03502317 Prehabilitation to Improve Cancer Surgery Outcomes https://ClinicalTrials.gov/show/NCT03502317 Recruiting Mount Sinai Hospital, Canada 2020-08-31
NCT03449030 A Study of TAK-164 in Participants With Advanced Gastrointestinal (GI) Cancer Expressing Guanylyl Cyclase C (GCC) https://ClinicalTrials.gov/show/NCT03449030 Completed Takeda 2020-02-27
NCT03445260 PeRioperative Optimization With Nutritional Supplements for Patients Undergoing GastRointEStinal Surgery for Cancer https://ClinicalTrials.gov/show/NCT03445260 Recruiting Hamilton Health Sciences Corporation 2020-04-01
NCT03411915 A Study of XmAb®18087 in Subjects With NET and GIST https://ClinicalTrials.gov/show/NCT03411915 Recruiting Xencor, Inc. 2021-03-31
NCT01218841 Pure Fish Oil Parenteral Lipid Emulsion in Patients With Gastrointestinal Cancer https://ClinicalTrials.gov/show/NCT01218841 Completed University of Sao Paulo 2008-11-30
NCT01204476 Cixutumumab, Everolimus, and Octreotide Acetate in Treating Patients With Advanced Low to Intermediate Grade Neuroendocrine Carcinoma https://ClinicalTrials.gov/show/NCT01204476 Completed National Cancer Institute (NCI) 2014-07-31
NCT01202409 CAPOX in KRAS Wild-Type Advanced Adenocarcinoma of the Small Bowel or Ampulla of Vater https://ClinicalTrials.gov/show/NCT01202409 Completed M.D. Anderson Cancer Center 2018-07-03
NCT01200316 Rocking Motion: Physiologic Effect on the Surgical Stress Response https://ClinicalTrials.gov/show/NCT01200316 Completed M.D. Anderson Cancer Center 2017-11-20
NCT01200121 Bevacizumab as a Palliative Treatment for Patients With Symptomatic Malignant Ascites Due to Advanced-stage Gastrointestinal Cancers https://ClinicalTrials.gov/show/NCT01200121 Completed AIO-Studien-gGmbH 2014-08-31
NCT01155258 Temsirolimus and Vinorelbine Ditartrate in Treating Patients With Unresectable or Metastatic Solid Tumors https://ClinicalTrials.gov/show/NCT01155258 Completed University of Southern California 2013-01-31
NCT01129310 First Line Study of Irinotecan, Capecitabine and Oxaliplatin in Metastatic Gastric or Gastroesophageal Cancer. https://ClinicalTrials.gov/show/NCT01129310 Completed AHS Cancer Control Alberta 2018-05-18
NCT01058655 RAD001 and AV-951 in Patients With Refractory, Metastatic Colorectal Cancer https://ClinicalTrials.gov/show/NCT01058655 Completed Dana-Farber Cancer Institute 2013-09-30
NCT01046864 Combination of Brivanib With 5-Fluorouracil/Leucovorin (5FU/LV) and 5-Fluorouracil/Leucovorin/Irinotecan (FOLFIRI) https://ClinicalTrials.gov/show/NCT01046864 Completed Bristol-Myers Squibb 2014-06-30
NCT01037049 Optimum Timing for Surgery After Pre-operative Radiotherapy 6 vs 12 Weeks https://ClinicalTrials.gov/show/NCT01037049 Active, not recruiting Royal Marsden NHS Foundation Trust 2014-12-08
NCT01016639 Study of Capecitabine and Oxaliplatin in Combination With Radiotherapy in Patients With Unresectable Gastro-Intestinal Cancer https://ClinicalTrials.gov/show/NCT01016639 Completed Lund University Hospital 2007-07-31
NCT01010126 Temsirolimus and Bevacizumab in Treating Patients With Advanced Endometrial, Ovarian, Liver, Carcinoid, or Islet Cell Cancer https://ClinicalTrials.gov/show/NCT01010126 Completed National Cancer Institute (NCI) 2017-03-13
NCT00990535 High Dose Somatostatin Analogues in Neuroendocrine Tumors https://ClinicalTrials.gov/show/NCT00990535 Completed Federico II University 2007-12-31
NCT00855452 Activated Allogeneic Lymphocytes for Induction Graft Versus Tumor Effect in Metastatic Solid Tumors https://ClinicalTrials.gov/show/NCT00855452 Completed Hadassah Medical Organization 2014-05-31
NCT00849979 Validating M.D. Anderson Symptom Inventory (MDASI-GI) in GI Cancer Patients Under Chemotherapy https://ClinicalTrials.gov/show/NCT00849979 Completed M.D. Anderson Cancer Center 2010-01-31
NCT02349958 Clinical Trial of Intraperitoneal Hyperthermic Chemotherapy https://ClinicalTrials.gov/show/NCT02349958 Recruiting Bay Area Gynecology Oncology 2022-01-31
NCT00826410 Prospective Study on the Value of Subcutaneous Drains in Gastrointestinal Surgery https://ClinicalTrials.gov/show/NCT00826410 Completed University Hospital Freiburg 2004-12-31
NCT03245788 Effectiveness of Lay Navigators in Meeting Cancer Patients’ Non-Clinical Needs: A Pilot Study https://ClinicalTrials.gov/show/NCT03245788 Completed Stanford University 2018-07-31
NCT02664974 Home Enteral Nutrition in Malnourished Patients With Gastrointestinal Cancer https://ClinicalTrials.gov/show/NCT02664974 Completed Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 2011-02-28
NCT02221700 Massage Therapy in Reducing Chemotherapy-Induced Peripheral Neuropathy in Patients With Gastrointestinal or Breast Malignancies https://ClinicalTrials.gov/show/NCT02221700 Active, not recruiting M.D. Anderson Cancer Center 2020-04-30
NCT03294252 Oxaliplatin in PIPAC for Nonresectable Peritoneal Metastases of Digestive Cancers https://ClinicalTrials.gov/show/NCT03294252 Recruiting Institut Cancerologie de l’Ouest 2019-09-12
NCT03037385 Phase 1/2 Study of the Highly-selective RET Inhibitor, Pralsetinib (BLU-667), in Patients With Thyroid Cancer, Non-Small Cell Lung Cancer, and Other Advanced Solid Tumors https://ClinicalTrials.gov/show/NCT03037385 Recruiting Blueprint Medicines Corporation 2021-12-31
NCT02837679 Oncogeriatric Intervention and Follow-up at Home https://ClinicalTrials.gov/show/NCT02837679 Active, not recruiting University of Aarhus 2019-09-30
NCT02575898 Feasibility of a Creative Writing Intervention in an Advanced Cancer Population: A Single Arm, Consecutive Cohort Study https://ClinicalTrials.gov/show/NCT02575898 Completed Dartmouth-Hitchcock Medical Center 2018-07-12
NCT01693445 S-1, Oxaliplatin, and Irinotecan for Advanced Gastrointestinal Cancer https://ClinicalTrials.gov/show/NCT01693445 Completed Hallym University Medical Center 2014-02-28
NCT04447443 Impact of Dietary Fiber as Prebiotics on Chemotherapy-related Diarrhea in Patients With Gastrointestinal Tumors https://ClinicalTrials.gov/show/NCT04447443 Recruiting Second Affiliated Hospital, School of Medicine, Zhejiang University 2021-06-30
NCT04426669 A Study of Metastatic Gastrointestinal Cancers Treated With Tumor Infiltrating Lymphocytes in Which the Gene Encoding the Intracellular Immune Checkpoint CISH Is Inhibited Using CRISPR Genetic Engineering https://ClinicalTrials.gov/show/NCT04426669 Recruiting Intima Bioscience, Inc. 2022-10-31
NCT03858712 EHR-embedded OCDT in Breast or GI Cancer https://ClinicalTrials.gov/show/NCT03858712 Recruiting Dana-Farber Cancer Institute 2021-03-31
NCT00793871 Safety And Efficacy Study Of Sunitinib Malate In Chinese Patients With Imatinib Resistant Or Intolerant Malignant Gastrointestinal Stromal Tumor https://ClinicalTrials.gov/show/NCT00793871 Completed Pfizer 2014-04-30
NCT00788957 Panitumumab Combination Study With Rilotumumab or Ganitumab in Wild-type Kirsten Rat Sarcoma Virus Oncogene Homolog (KRAS) Metastatic Colorectal Cancer (mCRC) https://ClinicalTrials.gov/show/NCT00788957 Completed Amgen 2012-02-29
NCT00752570 A Phase 2, Randomized, Double Blind, Placebo Controlled Study of AMG 386 in Combination With FOLFIRI in Subjects With Previously Treated Metastatic Colorectal Carcinoma https://ClinicalTrials.gov/show/NCT00752570 Completed Amgen 2010-09-30
NCT00725712 Study of GSK1363089 in Metastatic Gastric Cancer https://ClinicalTrials.gov/show/NCT00725712 Completed GlaxoSmithKline 2009-11-01
NCT00680901 LOGiC - Lapatinib Optimization Study in ErbB2 (HER2) Positive Gastric Cancer: A Phase III Global, Blinded Study Designed to Evaluate Clinical Endpoints and Safety of Chemotherapy Plus Lapatinib https://ClinicalTrials.gov/show/NCT00680901 Active, not recruiting Novartis 2012-09-24
NCT00660153 Study of Tivozanib (AV-951) Plus FOLFOX6 in Subjects With Advanced Colorectal Cancer and Other Gastrointestinal Cancers https://ClinicalTrials.gov/show/NCT00660153 Completed AVEO Pharmaceuticals, Inc. 2012-06-30
NCT00655655 Everolimus and Vatalanib in Treating Patients With Advanced Solid Tumors https://ClinicalTrials.gov/show/NCT00655655 Completed Mayo Clinic 2009-09-15
NCT00654160 Irinotecan, Fluorouracil, and Leucovorin in Treating Patients With Advanced Gastrointestinal Cancer https://ClinicalTrials.gov/show/NCT00654160 Completed Mayo Clinic 2010-11-30
NCT00602082 Capecitabine and Streptozocin With or Without Cisplatin in Treating Patients With Unresectable or Metastatic Neuroendocrine Tumors https://ClinicalTrials.gov/show/NCT00602082 Completed National Cancer Institute (NCI) 2009-12-31
NCT00585637 Vitamin D for Chemoprevention https://ClinicalTrials.gov/show/NCT00585637 Completed Dana-Farber Cancer Institute 2010-10-31
NCT00583674 Phase 2 Study of AMG 386 (20060439) in Combination With Cisplatin & Capecitabine in Subjects With Metastatic Gastric, Gastroesophageal Junction, or Distal Esophageal Adenocarcinoma https://ClinicalTrials.gov/show/NCT00583674 Completed Amgen 2010-03-31
NCT00570635 A Phase 2 Study of XL820 in Adults With Advanced GIST Resistant to Imatinib and/or Sunitinib https://ClinicalTrials.gov/show/NCT00570635 Completed Exelixis 2009-05-31
NCT00537121 Vorinostat, Irinotecan, Fluorouracil, and Leucovorin in Treating Patients With Advanced Upper Gastrointestinal Cancer https://ClinicalTrials.gov/show/NCT00537121 Completed Roswell Park Cancer Institute 2012-10-31
NCT00526669 Study For Patients With Untreated Gastric Cancer Who Will Receive Capecitabine And Lapatinib https://ClinicalTrials.gov/show/NCT00526669 Completed GlaxoSmithKline 2011-04-30
NCT00513357 Melatonin Versus Placebo and the Effect on Appetite in Advanced Cancer Patients https://ClinicalTrials.gov/show/NCT00513357 Completed M.D. Anderson Cancer Center 2012-12-31
NCT00486954 Lapatinib in Combination With Weekly Paclitaxel in Patients With ErbB2 Amplified Advanced Gastric Cancer https://ClinicalTrials.gov/show/NCT00486954 Completed GlaxoSmithKline 2012-01-31
NCT00465725 A Study Comparing Oral Picoplatin With Intravenous Picoplatin in Subjects With Solid Tumors https://ClinicalTrials.gov/show/NCT00465725 Completed Poniard Pharmaceuticals 2009-07-31
NCT00454363 Pazopanib Hydrochloride in Treating Patients With Advanced Neuroendocrine Cancer https://ClinicalTrials.gov/show/NCT00454363 Completed National Cancer Institute (NCI) 2014-03-31
NCT00436657 Continuous Hyperthermic Peritoneal Perfusion (CHPP) With Cisplatin for Children With Peritoneal Cancer https://ClinicalTrials.gov/show/NCT00436657 Completed M.D. Anderson Cancer Center 2011-04-30
NCT00436410 Tumor Necrosis Factor in Patients Undergoing Surgery for Primary Cancer or Metastatic Cancer https://ClinicalTrials.gov/show/NCT00436410 Completed National Institutes of Health Clinical Center (CC) NA
NCT00427349 AMG 706 and Octreotide in Treating Patients With Low-Grade Neuroendocrine Tumors https://ClinicalTrials.gov/show/NCT00427349 Completed Eastern Cooperative Oncology Group 2014-10-31
NCT00422409 Endoscopic Stenting of Gastrointestinal Cancer https://ClinicalTrials.gov/show/NCT00422409 Completed Oslo University Hospital 2009-04-30
NCT00416767 Combination Chemotherapy as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Neuroendocrine Tumors of the Duodenum or Pancreas That Cannot Be Removed By Surgery https://ClinicalTrials.gov/show/NCT00416767 Completed Federation Francophone de Cancerologie Digestive 2006-01-31
NCT00397384 Erlotinib Hydrochloride and Cetuximab in Treating Patients With Advanced Gastrointestinal Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer, or Colorectal Cancer https://ClinicalTrials.gov/show/NCT00397384 Completed National Cancer Institute (NCI) 2013-06-30
NCT00392366 Laser Interstitial Thermal Therapy Under “Real Time” MRI Guidance for “Minimal Invasive” Treatment of Liver Metastasis https://ClinicalTrials.gov/show/NCT00392366 Completed BioTex, Inc. NA
NCT00390182 Low Dose Upper Abdominal Radiation Therapy (LD-UART) + Gemcitabine in Patients With Advanced, Unresectable Pancreatic Cancer (PC) https://ClinicalTrials.gov/show/NCT00390182 Completed University of Maryland, Baltimore 2011-05-31
NCT00356889 Bevacizumab and Erlotinib Hydrochloride in Treating Patients With Metastatic or Unresectable Biliary Tumors https://ClinicalTrials.gov/show/NCT00356889 Completed National Cancer Institute (NCI) 2008-10-31
NCT00354887 Capecitabine and Oxaliplatin in Adenocarcinoma of the Small Bowel and Ampulla of Vater https://ClinicalTrials.gov/show/NCT00354887 Completed M.D. Anderson Cancer Center 2009-11-30
NCT00353015 Irinotecan and Cisplatin for High Grade Neuroendocrine Carcinoma of the Gastrointestinal Tract https://ClinicalTrials.gov/show/NCT00353015 Completed M.D. Anderson Cancer Center 2007-12-31
NCT00289445 Study With Mitomycin c/5-FU/FA in Pretreated Gastrointestinal Cancer Patients With Metastases (>= Second-line Treatment) https://ClinicalTrials.gov/show/NCT00289445 Completed University Hospital Tuebingen 2006-03-31
NCT00247338 The Impact of Low Calorie and Low Nitrogen Parenteral Nutrition Support on the Clinical Outcome of Postoperative Patients https://ClinicalTrials.gov/show/NCT00247338 Completed Sino-Swed Pharmaceutical Corporation 2006-04-30
NCT00220168 Phase II Trial Evaluating Irinotecan and Capecitabine Relapsed/Refractory Upper GI Tumours https://ClinicalTrials.gov/show/NCT00220168 Completed Royal Marsden NHS Foundation Trust NA
NCT00220064 A Phase II Trial Evaluating Irinotecan Plus 5FU/LV in Patients With Relapsed/Refractory Upper GI Tumours https://ClinicalTrials.gov/show/NCT00220064 Completed Royal Marsden NHS Foundation Trust NA
NCT00196885 Effect of an Antioxidant on Cancer-Cachectic Patients Undergoing Exercise Training https://ClinicalTrials.gov/show/NCT00196885 Completed German Cancer Research Center NA
NCT00190801 Phase 2 Study on Use of a Combination of Pemetrexed in Patients With Advanced Gastric Carcinoma https://ClinicalTrials.gov/show/NCT00190801 Completed Eli Lilly and Company NA
NCT00183846 Study of Irinotecan Administered as a Continuous Infusion and Radiation Therapy for Upper Gastrointestinal Cancers https://ClinicalTrials.gov/show/NCT00183846 Completed University of Southern California 2007-10-31
NCT00131911 Sorafenib Tosylate in Treating Patients With Progressive Metastatic Neuroendocrine Tumors https://ClinicalTrials.gov/show/NCT00131911 Completed National Cancer Institute (NCI) 2010-10-31
NCT00120939 Study of Motexafin Gadolinium and Docetaxel for Advanced Cancer https://ClinicalTrials.gov/show/NCT00120939 Completed Pharmacyclics LLC. NA
NCT00094965 Oxaliplatin With FOLFOX4 in Patients With Normal and Abnormal Renal Function https://ClinicalTrials.gov/show/NCT00094965 Completed Sanofi 2007-08-31
NCT00093782 Temsirolimus in Treating Patients With Metastatic Neuroendocrine Carcinoma https://ClinicalTrials.gov/show/NCT00093782 Completed National Cancer Institute (NCI) 2011-04-30
NCT00089960 Study of AMG 706 in Subjects With Advanced Gastrointestinal Stromal Tumors (GISTs) https://ClinicalTrials.gov/show/NCT00089960 Completed Amgen 2006-06-30
NCT00086762 Mindfulness Relaxation Compared With Relaxing Music and Standard Symptom Management Education in Treating Patients Who Are Undergoing Chemotherapy For Newly Diagnosed Solid Tumors https://ClinicalTrials.gov/show/NCT00086762 Active, not recruiting M.D. Anderson Cancer Center 2024-12-31
NCT00003427 Oxaliplatin Plus Irinotecan in Treating Patients With Metastatic Gastrointestinal Cancer https://ClinicalTrials.gov/show/NCT00003427 Completed Memorial Sloan Kettering Cancer Center 2002-04-30
NCT00019474 Combination Chemotherapy Plus Interferon Alfa Followed by Filgrastim in Treating Patients With Gastrointestinal Tract Cancer https://ClinicalTrials.gov/show/NCT00019474 Completed Montefiore Medical Center 2000-08-31
NCT00006368 Yttrium Y 90 SMT 487 in Treating Patients With Refractory or Recurrent Cancer https://ClinicalTrials.gov/show/NCT00006368 Completed Novartis 2003-11-30
NCT00017199 PS-341 in Treating Patients With Metastatic Neuroendocrine Tumors https://ClinicalTrials.gov/show/NCT00017199 Completed National Cancer Institute (NCI) NA
NCT00075439 Gefitinib in Treating Patients With Progressive Metastatic Neuroendocrine Tumors https://ClinicalTrials.gov/show/NCT00075439 Completed National Cancer Institute (NCI) 2007-05-31
NCT00004074 Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu https://ClinicalTrials.gov/show/NCT00004074 Completed National Cancer Institute (NCI) 2009-02-28
NCT00004911 Endoscopic Placement of Metal Stent in Patients With Cancer-Related Bowel Obstruction https://ClinicalTrials.gov/show/NCT00004911 Completed Northwestern University 2003-02-28
NCT00004910 Endoscopic Placement of Metal Stents in Treating Patients With Cancer- Related Duodenal Obstruction https://ClinicalTrials.gov/show/NCT00004910 Completed Northwestern University 2003-02-28
NCT00055809 Bevacizumab and PEG-Interferon Alfa-2b in Treating Patients With Metastatic or Unresectable Carcinoid Tumors https://ClinicalTrials.gov/show/NCT00055809 Completed National Cancer Institute (NCI) 2007-06-30
NCT00052962 Debulking and Chemotherapy With or Without Intraperitoneal Chemotherapy to Treat Peritoneal Carcinomatosis https://ClinicalTrials.gov/show/NCT00052962 Completed National Institutes of Health Clinical Center (CC) 2008-09-30
NCT00049023 Radiolabeled Octreotide in Treating Children With Advanced or Refractory Solid Tumors https://ClinicalTrials.gov/show/NCT00049023 Completed University of Iowa 2011-08-31
NCT00031681 7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007) https://ClinicalTrials.gov/show/NCT00031681 Completed National Cancer Institute (NCI) 2011-01-31
NCT00027638 Thalidomide in Treating Patients With Metastatic Neuroendocrine Tumors https://ClinicalTrials.gov/show/NCT00027638 Completed Memorial Sloan Kettering Cancer Center 2003-12-31
NCT00002470 Fluorouracil Plus Interferon Alfa in Treating Patients With Advanced Metastatic Carcinoid Tumors https://ClinicalTrials.gov/show/NCT00002470 Completed National Cancer Institute (NCI) NA
NCT00001431 A Phase I Trial of Gemcitabine and Radiation in Locally Advanced Unresectable Cancer of the Pancreas https://ClinicalTrials.gov/show/NCT00001431 Completed National Institutes of Health Clinical Center (CC) NA
NCT00041808 Magnetic-Targeted Doxorubicin in Treating Patients With Cancer Metastatic to the Liver https://ClinicalTrials.gov/show/NCT00041808 Completed FeRx NA

Observational Studiess

#If less then 500 studies

nct_id brief_title link overall_status source primary_completion_date
NCT03207594 Improving Evidence-Based Care for Cancer Patients https://ClinicalTrials.gov/show/NCT03207594 Recruiting Medical University of South Carolina 2020-12-31
NCT04369053 Prevention of Colorectal Cancer Through Multiomics Blood Testing https://ClinicalTrials.gov/show/NCT04369053 Recruiting Freenome, Inc. 2021-07-30
NCT03407040 Generation of Cancer Antigen-Specific T-cells From Human Induced Pluripotent Stem Cells (iPSC) for Research and Potential FutureTherapy https://ClinicalTrials.gov/show/NCT03407040 Completed National Institutes of Health Clinical Center (CC) 2019-09-30
NCT03410641 Long-term Cancer Risk in the Randomised Oslo Diet and Antismoking Study https://ClinicalTrials.gov/show/NCT03410641 Completed Oslo University Hospital 2017-06-30
NCT04042298 Microvascular Function in Patients Undergoing 5-Fluorouracil Chemotherapy https://ClinicalTrials.gov/show/NCT04042298 Recruiting Kansas State University 2020-06-30
NCT03130621 Screening of Hereditary Upper Gastrointestinal Cancer in China https://ClinicalTrials.gov/show/NCT03130621 Recruiting Peking University 2022-03-31
NCT03050333 Efficacy and Safety of Endoscopic Resection https://ClinicalTrials.gov/show/NCT03050333 Recruiting Fundacion Miguel Servet 2022-12-31
NCT02951273 Cerebral Blood Flow During Propofol Anaesthesia https://ClinicalTrials.gov/show/NCT02951273 Completed Rigshospitalet, Denmark 2017-07-06
NCT02909062 Beyond Performance Status: Electronic Activity Monitoring to Assess Functional Activity of Patients With Gastrointestinal Malignancy During Chemotherapy. https://ClinicalTrials.gov/show/NCT02909062 Active, not recruiting Memorial Sloan Kettering Cancer Center 2021-05-31
NCT02894775 Factors Influencing Inclusion in Digestive Cancer Clinical Trials https://ClinicalTrials.gov/show/NCT02894775 Completed Centre Hospitalier Universitaire Dijon 2013-12-31
NCT02781532 Evaluation of Predictive Visual Analog Scale (VAS) for Determining the Ingesta of Patients Carrying a Digestive Cancer https://ClinicalTrials.gov/show/NCT02781532 Completed Centre Hospitalier Universitaire de Nice 2015-01-31
NCT02583815 Feasibility of Activity Monitoring in Patients With Cancer: Physical Activity Monitoring in Cancer Patients (PAMCaP) https://ClinicalTrials.gov/show/NCT02583815 Completed University of Texas Southwestern Medical Center 2017-09-15
NCT02486094 Study of PRoliferation and Apoptosis in Rectal Cancer, Predictive & Prognostic biOmarkers: Histopathology and Imaging https://ClinicalTrials.gov/show/NCT02486094 Completed Royal Marsden NHS Foundation Trust 2016-09-01
NCT02454647 Induction Chemotherapy, Chemoradiotherapy and Surgery in Locally Advanced Gastric Cancer Patients https://ClinicalTrials.gov/show/NCT02454647 Completed Clinica Universidad de Navarra, Universidad de Navarra 2015-03-31
NCT02428101 Oxaliplatin - Induced Peripheral Neuropathy in Patients With Gastrointestinal Tract Cancer https://ClinicalTrials.gov/show/NCT02428101 Enrolling by invitation Ain Shams University 2020-07-31
NCT02226224 Endoscopic Ultrasound in Detailed T-staging of Upper GI Malignancies in Vitro https://ClinicalTrials.gov/show/NCT02226224 Recruiting Beijing Cancer Hospital 2020-10-31
NCT02196935 Los Angeles Prospective GI Biliary and EUS Series https://ClinicalTrials.gov/show/NCT02196935 Recruiting University of Southern California 2020-12-31
NCT02143869 Evolution of Corporeal Composition in the PeriOperative Period https://ClinicalTrials.gov/show/NCT02143869 Completed Hôpital Européen Marseille 2016-12-31
NCT02140463 Next Generation pErsonalized tX(Therapy) With Plasma DNA Trial-2 in Refractory Solid Tumors (The NEXT-2 Trial) https://ClinicalTrials.gov/show/NCT02140463 Recruiting Samsung Medical Center 2019-12-31
NCT02067754 Circulating Free DNA Analysis in Gastrointestinal Cancer, Genitourinary Cancer, Rare Cancer https://ClinicalTrials.gov/show/NCT02067754 Completed Samsung Medical Center 2018-01-31
NCT01313442 Acquisition of Blood and Tumor Tissue Samples From Patients With Gastrointestinal Cancer https://ClinicalTrials.gov/show/NCT01313442 Recruiting National Institutes of Health Clinical Center (CC) NA
NCT02005965 Low Rectal Cancer Study (MERCURY II) https://ClinicalTrials.gov/show/NCT02005965 Active, not recruiting Royal Marsden NHS Foundation Trust 2016-03-11
NCT01995942 Molecular, Pathologic and MRI Investigation of the Prognostic and Redictive Importance of Extramural Venous Invasion in Rectal Cancer (MARVEL) Trial https://ClinicalTrials.gov/show/NCT01995942 Active, not recruiting Royal Marsden NHS Foundation Trust 2017-02-02
NCT01831609 Biomarker Analysis of Solid Cancers Such as Gastrointestinal Cancer https://ClinicalTrials.gov/show/NCT01831609 Recruiting Samsung Medical Center 2019-12-31
NCT01816607 Functional MRI of Hypoxia-mediated Rectal Cancer Aggressiveness https://ClinicalTrials.gov/show/NCT01816607 Completed University Hospital, Akershus 2017-12-31
NCT01750619 Clinical Outcomes of the Endoscopic Resection of Premalignant and Malignant Gastrointestinal Lesions https://ClinicalTrials.gov/show/NCT01750619 Recruiting California Pacific Medical Center Research Institute 2021-12-31
NCT01718821 Assessments on Current Pain Managements in Upper Gastrointestinal Cancer Patients https://ClinicalTrials.gov/show/NCT01718821 Completed National Cheng Kung University 2013-09-30
NCT01658917 Collecting Solid Tumor Tissue to Identify New Treatments https://ClinicalTrials.gov/show/NCT01658917 Completed National Institutes of Health Clinical Center (CC) NA
NCT01487343 Patient Factors Impacting Adherence to Oral Chemotherapy https://ClinicalTrials.gov/show/NCT01487343 Completed Memorial Sloan Kettering Cancer Center 2016-11-30
NCT01416714 Tissue Procurement for Gastric Cancer, Gastrointestinal Stromal Tumors (GIST), Esophageal Cancer, Pancreas Cancer, Hepatocellular Cancer, Biliary Cancer, Neuroendocrine, Peritoneal Mesothelioma, Anal Cancer and Colorectal Cancer in Patients Undergoing Surgery or Biopsy https://ClinicalTrials.gov/show/NCT01416714 Recruiting University of Chicago 2025-01-31
NCT01415609 Endoscopic Submucosal Dissection Registry https://ClinicalTrials.gov/show/NCT01415609 Completed Mayo Clinic 2012-03-31
NCT04354064 Circulating Tumor DNA (ctDNA) for Early Treatment Response Assessment of Solid Tumors https://ClinicalTrials.gov/show/NCT04354064 Recruiting Washington University School of Medicine 2025-12-31
NCT04133324 C-protein Reactive for the Detection of Anastomotic Leakage After Surgery for Digestive Cancer https://ClinicalTrials.gov/show/NCT04133324 Recruiting Moroccan Society of Surgery 2023-12-31
NCT04081831 Effectiveness of Low Dose Aspirin in Decreasing the Chance Getting Stomach and Intestine Cancer https://ClinicalTrials.gov/show/NCT04081831 Active, not recruiting Bayer 2020-07-31
NCT04008056 Impact of Patient Reported Outcomes for Pre-chemotherapy Medical Decision in Day Patients With Digestive Cancer https://ClinicalTrials.gov/show/NCT04008056 Recruiting Centre Hospitalier Universitaire de Nīmes 2020-06-30
NCT03743883 EffectiveNess of Low-dose Aspirin in Prevention of Cancer in the Stomach and Oesophagus (GastrointEstinal Cancer Prevention) - United Kingdom (“ENgAGE - UK”): Study to Evaluate the Risk of Cancer in the Stomach and Oesophagus Among New Users of Low-dose Aspirin Using the THIN Database in the UK https://ClinicalTrials.gov/show/NCT03743883 Completed Bayer 2019-04-15
NCT03740503 Genomic Investigation of Unusual Responders https://ClinicalTrials.gov/show/NCT03740503 Active, not recruiting University Health Network, Toronto 2020-11-30
NCT03621852 Prospective Evaluation of the Diagnostic Efficacy of a EUS Guided FNB Needle (AQUIRE®) https://ClinicalTrials.gov/show/NCT03621852 Recruiting Philipps University Marburg Medical Center 2019-07-01
NCT03579732 EffectiveNess of Low Dose Aspirin in GastrointEstinal Cancer Prevention - Taiwan https://ClinicalTrials.gov/show/NCT03579732 Completed Bayer 2019-09-30
NCT03568019 PET Avidity in Cachexia-Inducing Lung and Gastrointestinal Tumors https://ClinicalTrials.gov/show/NCT03568019 Active, not recruiting University of Texas Southwestern Medical Center 2023-05-26
NCT03563352 Nutritional Preferences and Product Accessibility in Oral Nutritional Supplements in Participants With Breast, Colorectal, Upper Gastrointestinal, or Prostate Cancer https://ClinicalTrials.gov/show/NCT03563352 Recruiting University of Southern California 2020-08-30
NCT03433092 Serum Carotenoids and Risk of Gastrointestinal Tract Cancer: Meta-analysis of Ten Studies https://ClinicalTrials.gov/show/NCT03433092 Completed West China Hospital 2017-11-20
NCT01105806 Cardiopulmonary Resuscitation (CPR) Video to Enhance Advance Care Planning in Advanced Upper Gastrointestinal Cancer Patients https://ClinicalTrials.gov/show/NCT01105806 Completed Memorial Sloan Kettering Cancer Center 2015-07-31
NCT01621295 Assessing the Patient Experience in Cancer Care https://ClinicalTrials.gov/show/NCT01621295 Completed Mayo Clinic 2015-09-30
NCT01505400 Integrated Molecular Profiling in Advanced Cancers Trial https://ClinicalTrials.gov/show/NCT01505400 Active, not recruiting University Health Network, Toronto 2021-01-31
NCT02906943 Ontario-wide Cancer TArgeted Nucleic Acid Evaluation https://ClinicalTrials.gov/show/NCT02906943 Recruiting University Health Network, Toronto 2021-08-31
NCT00660205 Venous Thromboembolism and Haemostatic Disturbances in Patients With Upper Gastrointestinal Cancer https://ClinicalTrials.gov/show/NCT00660205 Completed University of Aarhus 2011-02-28
NCT00633334 Development of Early Detection Signs for Gastrointestinal Cancer https://ClinicalTrials.gov/show/NCT00633334 Completed University of Pittsburgh 2016-01-28
NCT00584363 Pancreatic and Gastrointestinal Tumor Registry and Tissue Collection https://ClinicalTrials.gov/show/NCT00584363 Completed University of Alabama at Birmingham 2017-09-30
NCT00364078 Transitoriness in Cancer Patients, Psychosocial Issues in Cancer Care https://ClinicalTrials.gov/show/NCT00364078 Completed Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 2007-05-31
NCT00068003 Harvesting Cells for Experimental Cancer Treatments https://ClinicalTrials.gov/show/NCT00068003 Enrolling by invitation National Institutes of Health Clinical Center (CC) NA

Registries

#If less then 500 registries

nct_id brief_title link overall_status source primary_completion_date
NCT04361227 Utility of OverStitch Sx After ESD https://ClinicalTrials.gov/show/NCT04361227 Recruiting Baylor College of Medicine 2021-12-31
NCT03286348 Analysis of Nutrition During Chemoradiotherapy in Patients With Gastrointestinal Cancer https://ClinicalTrials.gov/show/NCT03286348 Recruiting Fudan University 2018-09-01
NCT03205735 The Enzymatic Activity of Lymphocyte Dihydropyrimidine Dehydrogenase DPD in the Blood as a Predictive and Prognostic Factor in Patients With Digestive Cancer in the First or Second Metastatic Line https://ClinicalTrials.gov/show/NCT03205735 Recruiting Centre Antoine Lacassagne 2020-09-29
NCT03862378 Prediction of Intra-abdominal Infectious Complication by Drainage Fluid Analysis https://ClinicalTrials.gov/show/NCT03862378 Recruiting Peking University 2020-12-31
NCT03828266 Prediction of Abdominal Complications After GastroEnterological Surgery https://ClinicalTrials.gov/show/NCT03828266 Recruiting Peking University 2019-12-31
NCT03681600 Observatory of the Quality of Surgical Procedures for Digestive Cancers https://ClinicalTrials.gov/show/NCT03681600 Recruiting Moroccan Society of Surgery 2020-12-31